162997-21-9

Basic information

• Product Name: 1-(4-cyanophenyl)piperidine-4-carboxylic acid
• Synonyms: 1-(4-cyanophenyl)piperidine-4-carboxylic acid;1-(4-cyanophenyl)-4-piperidinecarboxylic acid
• CAS NO: 162997-21-9
• Molecular Formula: C₁₃H₁₄N₂O₂
• Molecular Weight: 230.26246
• Mol File: 162997-21-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 470.8±40.0 °C(Predicted)
• Appearance: /
• Density: 1.26±0.1 g/cm3(Predicted)
• PKA: 4.52±0.20(Predicted)
• CAS DataBase Reference: 1-(4-cyanophenyl)piperidine-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-cyanophenyl)piperidine-4-carboxylic acid(162997-21-9)
• EPA Substance Registry System: 1-(4-cyanophenyl)piperidine-4-carboxylic acid(162997-21-9)

Safety Data

• Hazardous Substances Data: 162997-21-9(Hazardous Substances Data)

Usage

General Description

1-(4-cyanophenyl)piperidine-4-carboxylic acid is a chemical compound with the molecular formula C14H16N2O2. It is a piperidine derivative containing a cyanophenyl group and a carboxylic acid group. 1-(4-cyanophenyl)piperidine-4-carboxylic acid may have potential applications in pharmacology and medicinal chemistry, as piperidine derivatives are known for their diverse biological activities. Additionally, the presence of the carboxylic acid group makes it a versatile building block for the synthesis of other organic compounds. Further research and investigation may reveal potential uses and applications for this chemical in the fields of drug development and material science.

Upstream product

• 498-94-2 isonipecotic acid 
• 1194-02-1 4-fluorobenzonitrile 
• 352018-90-7 1-(4-cyanophenyl)-piperidine-4-carboxylic acid ethyl ester 
• 1126-09-6 4-carbethoxypiperidine 

Downstream Products

• 799557-61-2 1-tert-butoxycarbonyl-4-[1-(4-cyanophenyl)-piperidine-4-carbonyl]-[1,4]diazepane 

Relevant articles and documents

1, 4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS

The present invention provides compounds of formula (1) compositions comprising such compounds; the use of such compounds in therapy (such as in the treatment of dysmenorrhoea); and methods of treating patients with such compounds; wherein A and G are as defined herein.

USE OF SUBSTITUTED 2 PHENYLBENZIMIDAZOLES AS MEDICAMENTS

The present invention relates to the use of a substituted 2-phenylbenzimidazole of formula I wherein R1, R2, R3, R 4, R5 and m have the meanings given in the claims, for the preparation of a medicament for the treatment or prevention of diseases involving glucagon receptors, as well as new compounds of formula I wherein R1 is a group of formula

USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS

The invention relates to the use of a substituted 2-phenylbenzimidazole of formula (I), where R1, R2, R3, R4, R5 and m have the meanings given in the claims, for the production of a medicament for the treatment or prevention of diseases in which glucagon receptors are implicated and novel compounds of formula (I), where R1 is a group of formula (II).